Clinical Trial News, p.2
Tue Aug 17 04:54:06 2010
(Xenon Pharmaceuticals Inc.)
Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
Thu Aug 12 14:42:38 2010
(Clearstone Central Laboratories)
Clearstone Central Laboratories and LabCorp Establish Global Strategic Collaboration for Clinical Trials
Wed Aug 11 12:09:07 2010
(Georgia Institute of Technology)
Initial trials on new ovarian cancer tests exhibit extremely high accuracy
Mon Aug 9 08:48:13 2010
(Lentigen Corporation)
Lentigen Awarded Phase II SBIR Grant for Clinical Development of TCR Immunotherapy Targeted to Melanoma
Thu Aug 5 04:06:18 2010
(YM BioSciences Inc.)
YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study
Tue Aug 3 12:12:15 2010
(Excaliard Pharmaceuticals, Inc.)
Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001
Tue Aug 3 08:24:08 2010
(Celsion Corporation)
Celsion's Phase III ThermoDox® HEAT Study Recommended as Priority Clinical Trial for HCC
Mon Aug 2 17:12:15 2010
(Children's Hospital Boston)
Drug Trials Funded by Industry Are More Likely to Publish Favorable Results
Mon Aug 2 13:25:03 2010
(BioMarin Pharmaceutical Inc.)
Encouraging Preliminary Safety and Efficacy Trends in Phase 2 Clinical Study of PEG-PAL in PKU
Mon Aug 2 13:24:07 2010
(BioMarin Pharmaceutical Inc.)
BioMarin Announces Results for Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy
Thu Jul 29 06:48:17 2010
(Intra-Cellular Therapies, Inc.)
Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia
Wed Jul 28 13:43:55 2010
(Angiotech Pharmaceuticals, Inc.)
Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients
Mon Jul 26 14:12:25 2010
(Regado Biosciences, Inc.)
Regado Biosciences Announces Publication in the American Heart Association Journal Circulation of the Results of a Phase 2a Study for the REG1 Anticoagulant System in Elective Percutaneous Interventions
Mon Jul 26 08:30:12 2010
(Hospira, Inc.)
Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
Mon Jul 26 04:42:15 2010
(Onyx Pharmaceuticals, Inc.)
Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data From Phase 2b Study
Sat Jul 24 18:33:07 2010
(Dana-Farber Cancer Institute)
Test could predict which children with T-cell ALL are best candidates for clinical trials
Thu Jul 22 05:42:40 2010
(Tibotec Pharmaceuticals)
TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective
Wed Jul 21 06:54:18 2010
(Onyx Pharmaceuticals, Inc.)
Onyx Pharmaceuticals Initiates a Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Tue Jul 20 15:00:52 2010
(PLoS: Neglected Tropical Diseases)
Health Education through Analogies: Preparation of a Community for Clinical Trials of a Vaccine against Hookworm in an Endemic Area of Brazil
Mon Jul 19 07:24:56 2010
(AEGERA THERAPEUTICS INC.)
Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Thu Jul 15 12:12:02 2010
(Group Zeltia)
Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimer's Disease at International Conference on Alzheimer's Disease (ICAD)
Wed Jul 7 06:36:15 2010
(Reportlinker)
Biomarkers in Late Stage Clinical Trials: Applications, opportunities and activities of leading players
Wed Jul 7 04:42:11 2010
(Nile Therapeutics, Inc.)
Nile Therapeutics Completes Dosing of Phase II Study
Tue Jul 6 15:24:17 2010
(Zeltia)
Sylentis Completes Phase I Trial with SYL040012 to Treat Elevated Intraocular Pressure and Glaucoma
Mon Jun 28 09:33:05 2010
(Massachusetts General Hospital)
Mass. General Hospital, Iacocca Foundation announce completion of Phase I diabetes trial
Fri Jun 25 15:18:11 2010
(Biodel Inc.)
Final Results of Phase 3 Study of VIAject® vs. Regular Human Insulin in Patients with Type 2 Diabetes Presented at American Diabetes Association Annual Meeting
Mon Jun 21 16:18:11 2010
(Lexicon Pharmaceuticals, Inc.)
Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
Sat Jun 19 14:54:11 2010
(Radius)
Radius Presents Positive Phase 2a Study Results Establishing Clinical Proof of Concept for RAD1901 in Reducing Menopausal Hot Flashes
Thu Jun 17 04:00:14 2010
(ChemoCentryx, Inc.)
ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR)
Tue Jun 15 04:30:03 2010
(Pieris AG)
Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound
Wed Jun 9 13:21:09 2010
(Indiana University School of Medicine)
Late-stage ovarian cancer shows promise in two-drug phase I trial
Wed Jun 9 09:33:14 2010
(University of Illinois at Chicago)
Compound enhances cancer-killing properties of agent in trials
Wed Jun 9 07:54:03 2010
(Nektar Therapeutics)
Nektar Therapeutics Announces Positive Initial Results from Phase 2 Study of NKTR-102 in Metastatic Breast Cancer
Wed Jun 9 04:06:27 2010
(S*BIO Pte Ltd)
S*BIO Completes Enrollment of Patients in Phase 2 Clinical Trials for its JAK2 Inhibitor SB1518
Sun Jun 6 05:48:22 2010
(NewLink Genetics Corporation)
NewLink Genetics' HyperAcute® Immunotherapy Phase 2 Study Shows Promise in Disease Free and Overall Survival for Resectable Pancreatic Cancer
Sun Jun 6 05:48:18 2010
(Alder Biopharmaceuticals Inc.)
Alder Biopharmaceuticals' ALD518 Antibody Therapeutic Reduces Disease Symptoms, Anemia in Phase 2a Clinical Trial in Non-Small Cell Lung Cancer Patients
Sat Jun 5 16:30:11 2010
(Onyx Pharmaceuticals, Inc.)
Onyx Pharmaceuticals' Carfilzomib Continues to Demonstrate Encouraging Results in Ongoing Phase 2 Multiple Myeloma Study
Sat Jun 5 07:00:33 2010
(NovoCure)
Successful Phase III Clinical Trial Results Reported for NovoCure's Novel Medical Device for Treatment of Recurrent Glioblastoma
Sat Jun 5 07:00:09 2010
(Amgen)
New Analyses of Denosumab Pivotal Phase 3 Trials Reinforce Potential Advantages Over Standard of Care
Fri Jun 4 21:33:07 2010
(University of Florida)
Oncologists fight leukemia with two-pronged therapy, clinical trials planned
Fri Jun 4 15:48:14 2010
(MedTrust Online LLC)
GlaxoSmithKline and MedTrust Online Team to Provide Cancer Doctors Better Mobile Access to Cancer Clinical Trials
Fri Jun 4 13:54:06 2010
(Onyx Pharmaceuticals, Inc.)
Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
Thu Jun 3 14:51:11 2010
(University of Florida)
UF oncologists fight leukemia with two-pronged therapy, clinical trials planned
Thu Jun 3 05:36:19 2010
(Cardinal Health, Inc.)
Cardinal Health Supports ACRIN Clinical Trials Evaluating Oncologic Biotracers
Wed Jun 2 23:54:20 2010
(Novartis Pharmaceuticals Corporation)
Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
Wed Jun 2 14:24:15 2010
(Cephalon, Inc.)
Cephalon Provides Clinical Update on Phase II Study of NUVIGIL as an Adjunctive Therapy in Adults with Schizophrenia
Wed May 26 11:24:10 2010
(Pacific Biomarkers, Inc.)
Pacific Biomarkers Awarded Major Research Contract as Part of Phase I Cardiovascular Program
Fri May 21 06:00:19 2010
(YM BioSciences Inc.)
YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting
Thu May 20 16:43:36 2010
(Nektar Therapeutics)
NKTR-102 Phase 2 Clinical Data Accepted for Oral Presentation at 2010 ASCO Annual Meeting
Thu May 20 12:54:04 2010
(Jennerex, Inc.)
Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously
Thu May 20 05:18:18 2010
(NewLink Genetics)
NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting
Tue May 18 11:30:10 2010
(Oncolytics Biotech Inc.)
Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
Tue May 18 07:42:10 2010
(Karolinska Development and Aprea)
Aprea to Present Phase I/II Trial Design
Mon May 17 05:06:16 2010
(Mpex Pharmaceuticals, Inc.)
Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results of Aeroquin(TM) (MP-376) Treatment in Cystic Fibrosis Patients
Tue May 11 04:42:35 2010
(EntreMed, Inc.)
EntreMed Initiates Second Site in ENMD-2076 Phase 2 Ovarian Cancer Study
Mon May 10 19:12:27 2010
(CrystalGenomics, Inc.)
CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
Mon May 10 05:54:14 2010
(Encorium Group, Inc.)
Encorium Group, Inc. Announces New Business Contract Wins of $6.8 Million, Including Two Pivotal Phase III Studies for a Major Asian Technology Company
Wed May 5 17:39:15 2010
(Helmholtz Association of German Research Centres)
Viruses effective against brain cancer in animals: Human trials set to start
Tue May 4 07:24:09 2010
(Anavex Life Sciences Corp.)
Anavex reports animal study results as lead Alzheimer's compound approaches phase 1 clinical trials
Mon May 3 04:48:12 2010
(Takeda Global Research & Development Center, Inc., U.S.)
Pivotal Phase 3 Data Demonstrated Investigational Compound Azilsartan Medoxomil Lowered Blood Pressure in Head-to-Head Comparator Trials
Fri Apr 30 10:18:07 2010
(US Oncology, Inc.)
US Oncology Meets With Leading Pharmaceutical and Biotech Companies to Design Clinical Trials for the Cancer Fighting Drugs of Tomorrow
Fri Apr 23 05:24:20 2010
(Oncolytics Biotech Inc.)
Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
Tue Apr 20 05:12:09 2010
(Celsion Corporation)
Celsion Announces Oral Presentation of Phase I ThermoDox(R) Data At 2010 IHPBA World Congress
Mon Apr 19 06:24:12 2010
(Jennerex, Inc.)
Positive Interim Results for JX-594 Randomized Phase 2 Liver Cancer Trial Presented at Major International Conference (EASL)
Mon Apr 19 00:42:13 2010
(Stallergenes)
Stallergenes: Positive Results for Oralair(R) Phase III Trial in the USA
Thu Apr 15 11:12:06 2010
(Celsion Corporation)
Celsion Announces Long-Term Follow-Up Data From Phase 1 ThermoDox(R) Trial is Presented at the University of Hong Kong Press Conference
Thu Apr 15 03:36:20 2010
(Anadys Pharmaceuticals, Inc.)
72% of Patients Receiving ANA598 in Phase II Combination Study With Interferon and Ribavirin Achieve Undetectable Levels of Virus at Week Eight
Thu Apr 15 01:42:13 2010
(Idenix Pharmaceuticals, Inc.)
Idenix Pharmaceuticals Reports Positive Results With IDX184 From Interim Analysis of Phase IIa Hepatitis C Study
Wed Apr 14 04:48:10 2010
(InterMune, Inc.)
InterMune Reports Top-Line Results From Phase 2b Study of Danoprevir (RG7227/ITMN-191) in Patients with Chronic Hepatitis C
Tue Apr 13 13:36:10 2010
(Neurocrine Biosciences, Inc.)
Neurocrine Biosciences Announces the Initiation of Second VMAT2 Phase I Clinical Trial
Mon Apr 12 09:06:16 2010
(Kendle International Inc.)
Kendle Executives to Share Insights at 19th Annual Partnerships in Clinical Trials Conference
Thu Apr 8 06:18:04 2010
(AETERNA ZENTARIS INC.)
Aeterna Zentaris Announces Initiation of Phase 3 Registration Trial with Perifosine in Refractory Advanced Colorectal Cancer
Wed Apr 7 09:09:10 2010
(American Chemical Society)
Potential new Alzheimer's drugs advancing in clinical trials
Mon Mar 29 16:24:15 2010
(GenVec, Inc.)
GenVec Discontinues Phase 3 Clinical Trial of TNFerade(TM)
Wed Mar 17 06:09:09 2010
(Zogenix, Inc.)
Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone
Mon Mar 15 15:09:11 2010
(Nuvo Research Inc.)
Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial
Tue Mar 9 23:36:17 2010
(Amsterdam Molecular Therapeutics B.V)
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Mon Mar 8 06:39:05 2010
(Nektar Therapeutics)
Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer
Fri Mar 5 12:21:27 2010
(Poniard Pharmaceuticals, Inc.)
Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium
Wed Mar 3 13:33:06 2010
(Anavex Life Sciences Corp.)
Anavex comments on failure of Pfizer and Medivation's Alzheimer's investigational drug Dimebon during Phase 3 clinical trials
Thu Feb 4 04:12:11 2010
(TheStreet)
10 Biotech Stocks on Clinical Trials Watch
Tue Feb 2 07:15:16 2010
(Society of Nuclear Medicine)
Workshop examines successful integration of imaging biomarkers into clinical trials
Tue Dec 15 06:09:23 2009
(Reuters Health)
AIDS prevention gel fails in African trials
Sun Dec 13 23:00:12 2009
(TheStreet)
Roche-ImmunoGen to Start T-DM1 Trials
Tue Dec 8 12:15:14 2009
(University of Texas Health Science Center at Houston)
UT Houston researchers launch phase II trial of stem cells and acute heart attack
Thu Dec 3 06:18:06 2009
(Reuters)
Cubist Pharma halts enrollment in trials on safety concerns
Fri Oct 23 03:57:10 2009
(TheStreet)
Biotech Calendar: Key Upcoming Trials
Sun Oct 18 10:45:10 2009
(Yates Public Relations)
Angiochem crosses BBB, shows safety, efficacy in phase 1/2 brain cancer studies
Fri Oct 9 14:12:23 2009
(NIH/National Institute of Allergy and Infectious Diseases)
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
Mon Sep 28 06:00:06 2009
(Reuters)
UPDATE 1-Zymogenetics says Merck Serono discontinues MS trials
Mon Sep 28 05:54:05 2009
(AP Health)
Volunteers key to success of Thai vaccine trials
Thu Sep 24 07:57:07 2009
(ECCO-the European CanCer Organisation)
New Cancer Drug Test Promises Safer And More Effective Clinical Trials
Thu Sep 24 07:51:59 2009
(PRNewswire Biotech)
Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
Wed Sep 23 04:18:24 2009
(ECCO-the European CanCer Organisation)
New cancer drug test promises safer and more effective clinical trials
Mon Sep 21 09:40:11 2009
(PRNewswire Biotech)
Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors
Thu Sep 17 06:13:06 2009
(PRNewswire Biotech)
Intarcia Therapeutics, Inc. Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes
Wed Sep 16 08:46:19 2009
(PRNewswire Biotech)
Late Breaking Clinical Trials Presented at HFSA 13th Annual Scientific Meeting
Wed Sep 16 08:46:14 2009
(PRNewswire Biotech)
Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis
Wed Sep 16 05:24:07 2009
(Reuters)
UPDATE 1-Savient: FDA does not see more trials for gout drug
Wed Sep 16 00:57:55 2009
(PRNewswire Biotech)
18 month Follow-up Data on Phase III Study of Pixantrone in Late Stage Relapsed or Refractory, Aggressive Non-Hodgkin's Lymphoma Continues to Demonstrate Significant Improvement in Complete Remission and Progression Free Survival Over Standard Chemotherap
|
